aluates Reports

$ 0.0

Automative

Global Immunotherapy Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-14L16283

Immunotherapy Drugs Global Market Insights and Sales Trends 2024

BUY CHAPTERS

Global Immunotherapy Drugs Market Research Report 2025

Code: QYRE-Auto-14L16283

Report

September 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Merck

Novartis

Johnson & Johnson

GlaxoSmithKline PLC

Amgen Inc

AbbVie

Astrazeneca plc

Bristol–Myers Squibb

Eli Lilly

Immunotherapy Drugs Market Size

The global market for Immunotherapy Drugs was valued at US$ 241860 million in the year 2024 and is projected to reach a revised size of US$ 484920 million by 2031, growing at a CAGR of 10.6% during the forecast period.

Immunotherapy Drugs Market

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.

North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.

This report aims to provide a comprehensive presentation of the global market for Immunotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy Drugs.

The Immunotherapy Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immunotherapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunotherapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immunotherapy Drugs Market Report

Report Metric	Details
Report Name	Immunotherapy Drugs Market
Accounted market size in year	US$ 241860 million
Forecasted market size in 2031	US$ 484920 million
CAGR	10.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Adult Vaccines Checkpoint Inhibitors Interferons Alpha & Beta Interleukins Others
Segment by Application	Cancer Autoimmune & Inflammatory Diseases Infectious Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Merck, Novartis, Johnson & Johnson, Glaxosmithkline, Amgen, Abbvie, Astrazeneca, Bristol-Myers Squibb, ELI Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapy Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Immunotherapy Drugs Market growing?

Ans: The Immunotherapy Drugs Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the Immunotherapy Drugs Market size in 2031?

Ans: The Immunotherapy Drugs Market size in 2031 will be US$ 484920 million.

Who are the main players in the Immunotherapy Drugs Market report?

Ans: The main players in the Immunotherapy Drugs Market are Roche, Merck, Novartis, Johnson & Johnson, Glaxosmithkline, Amgen, Abbvie, Astrazeneca, Bristol-Myers Squibb, ELI Lilly

What are the Application segmentation covered in the Immunotherapy Drugs Market report?

Ans: The Applications covered in the Immunotherapy Drugs Market report are Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others

What are the Type segmentation covered in the Immunotherapy Drugs Market report?

Ans: The Types covered in the Immunotherapy Drugs Market report are Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunotherapy Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Adult Vaccines

1.2.4 Checkpoint Inhibitors

1.2.5 Interferons Alpha & Beta

1.2.6 Interleukins

1.2.7 Others

1.3 Market by Application

1.3.1 Global Immunotherapy Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Autoimmune & Inflammatory Diseases

1.3.4 Infectious Diseases

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunotherapy Drugs Market Perspective (2020-2031)

2.2 Global Immunotherapy Drugs Growth Trends by Region

2.2.1 Global Immunotherapy Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Immunotherapy Drugs Historic Market Size by Region (2020-2025)

2.2.3 Immunotherapy Drugs Forecasted Market Size by Region (2026-2031)

2.3 Immunotherapy Drugs Market Dynamics

2.3.1 Immunotherapy Drugs Industry Trends

2.3.2 Immunotherapy Drugs Market Drivers

2.3.3 Immunotherapy Drugs Market Challenges

2.3.4 Immunotherapy Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immunotherapy Drugs Players by Revenue

3.1.1 Global Top Immunotherapy Drugs Players by Revenue (2020-2025)

3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Immunotherapy Drugs Revenue

3.4 Global Immunotherapy Drugs Market Concentration Ratio

3.4.1 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Drugs Revenue in 2024

3.5 Global Key Players of Immunotherapy Drugs Head office and Area Served

3.6 Global Key Players of Immunotherapy Drugs, Product and Application

3.7 Global Key Players of Immunotherapy Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immunotherapy Drugs Breakdown Data by Type

4.1 Global Immunotherapy Drugs Historic Market Size by Type (2020-2025)

4.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2026-2031)

5 Immunotherapy Drugs Breakdown Data by Application

5.1 Global Immunotherapy Drugs Historic Market Size by Application (2020-2025)

5.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Immunotherapy Drugs Market Size (2020-2031)

6.2 North America Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Immunotherapy Drugs Market Size by Country (2020-2025)

6.4 North America Immunotherapy Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immunotherapy Drugs Market Size (2020-2031)

7.2 Europe Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Immunotherapy Drugs Market Size by Country (2020-2025)

7.4 Europe Immunotherapy Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immunotherapy Drugs Market Size (2020-2031)

8.2 Asia-Pacific Immunotherapy Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Immunotherapy Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Immunotherapy Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immunotherapy Drugs Market Size (2020-2031)

9.2 Latin America Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Immunotherapy Drugs Market Size by Country (2020-2025)

9.4 Latin America Immunotherapy Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immunotherapy Drugs Market Size (2020-2031)

10.2 Middle East & Africa Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Immunotherapy Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Immunotherapy Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Immunotherapy Drugs Introduction

11.1.4 Roche Revenue in Immunotherapy Drugs Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Immunotherapy Drugs Introduction

11.2.4 Merck Revenue in Immunotherapy Drugs Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Immunotherapy Drugs Introduction

11.3.4 Novartis Revenue in Immunotherapy Drugs Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Immunotherapy Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Glaxosmithkline

11.5.1 Glaxosmithkline Company Details

11.5.2 Glaxosmithkline Business Overview

11.5.3 Glaxosmithkline Immunotherapy Drugs Introduction

11.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2020-2025)

11.5.5 Glaxosmithkline Recent Development

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Immunotherapy Drugs Introduction

11.6.4 Amgen Revenue in Immunotherapy Drugs Business (2020-2025)

11.6.5 Amgen Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Details

11.7.2 Abbvie Business Overview

11.7.3 Abbvie Immunotherapy Drugs Introduction

11.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2020-2025)

11.7.5 Abbvie Recent Development

11.8 Astrazeneca

11.8.1 Astrazeneca Company Details

11.8.2 Astrazeneca Business Overview

11.8.3 Astrazeneca Immunotherapy Drugs Introduction

11.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2020-2025)

11.8.5 Astrazeneca Recent Development

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Immunotherapy Drugs Introduction

11.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2020-2025)

11.9.5 Bristol-Myers Squibb Recent Development

11.10 ELI Lilly

11.10.1 ELI Lilly Company Details

11.10.2 ELI Lilly Business Overview

11.10.3 ELI Lilly Immunotherapy Drugs Introduction

11.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2020-2025)

11.10.5 ELI Lilly Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Merck

Novartis

Johnson & Johnson

GlaxoSmithKline PLC

Amgen Inc

AbbVie

Astrazeneca plc

Bristol–Myers Squibb

Eli Lilly

List of Tables

Table 1. Global Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Adult Vaccines

Table 4. Key Players of Checkpoint Inhibitors

Table 5. Key Players of Interferons Alpha & Beta

Table 6. Key Players of Interleukins

Table 7. Key Players of Others

Table 8. Global Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Immunotherapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Immunotherapy Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Immunotherapy Drugs Market Share by Region (2020-2025)

Table 12. Global Immunotherapy Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Immunotherapy Drugs Market Share by Region (2026-2031)

Table 14. Immunotherapy Drugs Market Trends

Table 15. Immunotherapy Drugs Market Drivers

Table 16. Immunotherapy Drugs Market Challenges

Table 17. Immunotherapy Drugs Market Restraints

Table 18. Global Immunotherapy Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Immunotherapy Drugs Market Share by Players (2020-2025)

Table 20. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2024)

Table 21. Ranking of Global Top Immunotherapy Drugs Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Immunotherapy Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Immunotherapy Drugs, Headquarters and Area Served

Table 24. Global Key Players of Immunotherapy Drugs, Product and Application

Table 25. Global Key Players of Immunotherapy Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Immunotherapy Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Immunotherapy Drugs Revenue Market Share by Type (2020-2025)

Table 29. Global Immunotherapy Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Immunotherapy Drugs Revenue Market Share by Type (2026-2031)

Table 31. Global Immunotherapy Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Immunotherapy Drugs Revenue Market Share by Application (2020-2025)

Table 33. Global Immunotherapy Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Immunotherapy Drugs Revenue Market Share by Application (2026-2031)

Table 35. North America Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Immunotherapy Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Immunotherapy Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Immunotherapy Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 50. Roche Company Details

Table 51. Roche Business Overview

Table 52. Roche Immunotherapy Drugs Product

Table 53. Roche Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 54. Roche Recent Development

Table 55. Merck Company Details

Table 56. Merck Business Overview

Table 57. Merck Immunotherapy Drugs Product

Table 58. Merck Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 59. Merck Recent Development

Table 60. Novartis Company Details

Table 61. Novartis Business Overview

Table 62. Novartis Immunotherapy Drugs Product

Table 63. Novartis Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 64. Novartis Recent Development

Table 65. Johnson & Johnson Company Details

Table 66. Johnson & Johnson Business Overview

Table 67. Johnson & Johnson Immunotherapy Drugs Product

Table 68. Johnson & Johnson Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 69. Johnson & Johnson Recent Development

Table 70. Glaxosmithkline Company Details

Table 71. Glaxosmithkline Business Overview

Table 72. Glaxosmithkline Immunotherapy Drugs Product

Table 73. Glaxosmithkline Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 74. Glaxosmithkline Recent Development

Table 75. Amgen Company Details

Table 76. Amgen Business Overview

Table 77. Amgen Immunotherapy Drugs Product

Table 78. Amgen Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 79. Amgen Recent Development

Table 80. Abbvie Company Details

Table 81. Abbvie Business Overview

Table 82. Abbvie Immunotherapy Drugs Product

Table 83. Abbvie Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 84. Abbvie Recent Development

Table 85. Astrazeneca Company Details

Table 86. Astrazeneca Business Overview

Table 87. Astrazeneca Immunotherapy Drugs Product

Table 88. Astrazeneca Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 89. Astrazeneca Recent Development

Table 90. Bristol-Myers Squibb Company Details

Table 91. Bristol-Myers Squibb Business Overview

Table 92. Bristol-Myers Squibb Immunotherapy Drugs Product

Table 93. Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 94. Bristol-Myers Squibb Recent Development

Table 95. ELI Lilly Company Details

Table 96. ELI Lilly Business Overview

Table 97. ELI Lilly Immunotherapy Drugs Product

Table 98. ELI Lilly Revenue in Immunotherapy Drugs Business (2020-2025) & (US$ Million)

Table 99. ELI Lilly Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Immunotherapy Drugs Picture

Figure 2. Global Immunotherapy Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Immunotherapy Drugs Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Adult Vaccines Features

Figure 6. Checkpoint Inhibitors Features

Figure 7. Interferons Alpha & Beta Features

Figure 8. Interleukins Features

Figure 9. Others Features

Figure 10. Global Immunotherapy Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Immunotherapy Drugs Market Share by Application: 2024 VS 2031

Figure 12. Cancer Case Studies

Figure 13. Autoimmune & Inflammatory Diseases Case Studies

Figure 14. Infectious Diseases Case Studies

Figure 15. Others Case Studies

Figure 16. Immunotherapy Drugs Report Years Considered

Figure 17. Global Immunotherapy Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Immunotherapy Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Immunotherapy Drugs Market Share by Region: 2024 VS 2031

Figure 20. Global Immunotherapy Drugs Market Share by Players in 2024

Figure 21. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2024

Figure 23. North America Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Immunotherapy Drugs Market Share by Country (2020-2031)

Figure 25. United States Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Immunotherapy Drugs Market Share by Country (2020-2031)

Figure 29. Germany Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Immunotherapy Drugs Market Share by Region (2020-2031)

Figure 37. China Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Immunotherapy Drugs Market Share by Country (2020-2031)

Figure 45. Mexico Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Immunotherapy Drugs Market Share by Country (2020-2031)

Figure 49. Turkey Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Roche Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 55. Johnson & Johnson Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 56. Glaxosmithkline Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 57. Amgen Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 58. Abbvie Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 59. Astrazeneca Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 61. ELI Lilly Revenue Growth Rate in Immunotherapy Drugs Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunotherapy Market Insights Forecast to 2030

Global Cancer Immunotherapies Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global T Cell Immunotherapy Market Research Report 2025

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

Global Cell Immunotherapy Platform Market Research Report 2024

Oncology Immunotherapy Market

Global Immune Cell Therapy Drugs Market Research Report 2025

Global TCR T Cellular Immunotherapy Market Research Report 2024

Global Tumor Immune Cell Therapy Market Research Report 2024

Global Immunocell Therapy Market Insights Forecast to 2030

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions